CCL11 and Cognitive impairment: Patients with cognitive impairment in PCS showed higher CCL11/eotaxin-1 plasma values than patients with non-cognitive PCS symptoms, a cytokine that leads to specific reactivity of hippocampal microglia and impaired hippocampal neurogenesis in mice after systemic application29.